Three patient advocacy groups sue HHS and the Centers for Medicare and Medicaid Services over their support for insurance companies and pharmacy benef...
Beam Therapeutics says it will complete studies requested by FDA as part of a clinical hold on a Beam-201 cancer treatment IND and submit its response...
FDA warns Missoula, MT-based Elite One Source Nutritional Services about dietary supplement CGMP and misbranding violations.
The Medical Device Information Consortium publishes information from a working group looking at the benefits of and approaches to using patient prefer...
FDA commissioner Robert Califf says the agency has launched a drug overdose prevention framework with four overarching priorities.
FDA lifts a partial clinical hold on Curis TakeAim Leukemia study that is intended to evaluate emavusertib in a monotherapy phase of the trial.
Hamilton Medical recalls its Hamilton-C6 Intensive Care Ventilator after customer complaints were received about a hardware issue with the ventilators...
Outlook Therapeutics resubmits to FDA a BLA for its ONS-5010 to treat wet age-related macular degeneration.
